BIOMAT Database Logo BIOMAT Database Logo

Immunochemical similarity of P-450 HFLa, a form of cytochrome P-450 in human fetal livers, to a form of rat liver cytochrome P-450 inducible by macrolide antibiotics. 1988

M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

A protein immunochemically related to P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, was detected in rat liver microsomes. The content of the immunoreactive protein in rat liver microsomes was increased by treatments with phenobarbital, pregnenolone 16 alpha-carbonitrile (PCN), erythromycin, erythromycin estolate, and oleandomycin but not with 3-methylcholanthrene, imidazole, ethanol, isosafrole, josamycin, midecamycin, or miocamycin. The activity of erythromycin N-demethylase correlated with the content of the immunoreactive protein in rat liver microsomes (r = 0.72). In addition, anti-P-450 HFLa IgG inhibited erythromycin N-demethylase in liver microsomes from erythromycin- or oleandomycin-pretreated rats. Furthermore, the content of the immunoreactive protein highly correlated with that of P-450 PB-1, which is distinct from Waxman's terminology, and is one of the forms of PCN-inducible cytochrome P-450s (r = 0.95). From these results and the results reported so far, it seems possible that P-450 HFLa is one of the forms of cytochrome P-450 inducible by glucocorticoids.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009827 Oleandomycin Antibiotic macrolide produced by Streptomyces antibioticus. Oleandomycin Phosphate,Phosphate, Oleandomycin
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal

Related Publications

M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
[Cytochrome P-450 in human fetal liver. Properties of P-450 HFLa,a form of cytochrome P-450 in human fetal livers].
March 1991, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
Immunochemical studies for the presence of P-450 HFLa, a form of cytochrome P-450 in human fetal livers in human hepatocellular carcinoma cells.
June 1989, Journal of pharmacobio-dynamics,
M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
Immunochemical examinations of cytochrome P-450 in various tissues of human fetuses using antibodies to human fetal cytochrome P-450, P-450 HFLa.
September 1985, Biochemical and biophysical research communications,
M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations.
February 1987, Biochemical pharmacology,
M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate.
October 1987, The Journal of biological chemistry,
M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
Mutagenic activation of aflatoxin B1 by P-450 HFLa in human fetal livers.
September 1989, Mutation research,
M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
Decrease in a constitutive form of cytochrome P-450 by macrolide antibiotics.
October 1989, The Journal of antimicrobial chemotherapy,
M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
Human fetal liver cytochrome P-450: capacity to form genotoxic metabolites.
October 1992, The Tohoku journal of experimental medicine,
M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
Identification of an inducible form of cytochrome P-450 in human liver.
September 1985, Proceedings of the National Academy of Sciences of the United States of America,
M Kitada, and N Igoshi, and T Kamataki, and K Itahashi, and S Imaoka, and M Komori, and Y Funae, and T Rikihisa, and Y Kanakubo
Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p.
April 1985, Biochemistry,
Copied contents to your clipboard!